- In the
management of Parkinson's disease, due to the
chronic nature of Parkinson's
disease (PD), a broad-based
program is
needed that
includes patient...
-
Boutin JA, Newman-Tancredi A (November 2002). "Differential
actions of
antiparkinson agents at
multiple classes of
monoaminergic receptor. I. A multivariate...
- however, that the
greater affinity bromocriptine and many
similar antiparkinson's drugs have for the D2S
receptor form (considered to be
mostly present...
- pseudoephedrine),
antidepressants (e.g.
bupropion and phenelzine),
antiparkinson agents (e.g., selegiline), and
vasopressors (e.g., ephedrine), among...
-
Boutin JA, Newman-Tancredi A (November 2002). "Differential
actions of
antiparkinson agents at
multiple classes of
monoaminergic receptor. I. A multivariate...
- are
weight loss
drugs such as
fenfluramine and chlorphentermine, and
antiparkinson drugs such as
pergolide and cabergoline,
which are
prescribed for chronic...
-
Boutin JA, Newman-Tancredi A (November 2002). "Differential
actions of
antiparkinson agents at
multiple classes of
monoaminergic receptor. I. A multivariate...
-
Ceuninck F,
Boutin JA,
Millan MJ (November 2002). "Differential
actions of
antiparkinson agents at
multiple classes of
monoaminergic receptor. II.
Agonist and...
-
Boutin JA, Newman-Tancredi A (November 2002). "Differential
actions of
antiparkinson agents at
multiple classes of
monoaminergic receptor. I. A multivariate...
-
together with the
neurologist Walther Birkmayer dramatic therapeutic antiparkinson effects of
intravenously administered l-DOPA in patients. This treatment...